US 9669091
Vaccines having an antigen and interleukin-23 as an adjuvant
granted A61KA61K2039/53A61K2039/54
Quick answer
US patent 9669091 (Vaccines having an antigen and interleukin-23 as an adjuvant) held by Inovio Pharmaceuticals, Inc. expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/53, A61K2039/54, A61K2039/55527, A61K39/015